載入...
Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies
The approval of (223)Ra dichloride ((223)RaCl(2)) in 2013 was a principal event in introducing targeted α-therapy as a form of safe and effective management strategy in cancer. There is an increasing interest in research and development of new targeted α-therapy agents spearheaded by advancements in...
Na minha lista:
| 發表在: | Cancer Biother Radiopharm |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Mary Ann Liebert, Inc., publishers
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475102/ https://ncbi.nlm.nih.gov/pubmed/32202923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2019.3340 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|